Brief: China NT Pharma Posts HY Loss Attributable RMB28.2 Million
31/08/2022 14:05
Aug 31 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* HY LOSS ATTRIBUTABLE RMB28.2 MILLION VERSUS LOSS RMB2.7
MILLION
* HY REVENUE RMB120.5 MILLION VERSUS RMB111.2 MILLION
Source text for Eikon: ID:nHKS1zX2Hw
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma Co
See all newsBrief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
Brief: China NT Pharma Makes Application For Resumption Of Trading On Feb 11
Brief: HKEX Says Trading In Shares Of China NT Pharma Group Company Halted
Brief: China Nt Pharma Group Says To Issue Bonds In Aggregate Principal Amount Of HK$65 Million